URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://beyondspringpharma.com/subgroup-analysis-of-non-squamous-egfr-wild-type-wt-2nd-3rdline-nsclc-patients-from-the-global-phase-3-trial-dublin-3-bpi-2358-103-with-the-plinabulin-docetaxel-combination-vs-docetaxel-alone-20/ | 20% | Monthly | 2022-10-21 19:04 |